What's New

Drug Enforcement Administration, Department of Justice
March 8, 2024
DEA supports collaboration amongst all DEA registrants to ensure there is an adequate and uninterrupted supply of MOUD products when appropriately prescribed. Distributors should carefully examine any quantitative thresholds they have established to ensure that individuals with opioid use disorder (OUD) who need buprenorphine are able to access it without undue delay.
U.S. Department of Health and Human Services
February 1, 2024
Today, the U.S. Department of Health and Human Services (HHS) marked two years of its Overdose Prevention Strategy 
Moving People to Action, 2017 Steering Committee Meeting
August 2, 2023
The American Academy of Addiction Psychiatry (AAAP) is excited to announce that the Substance Abuse and Mental Health Services Administration (SAMHSA) has funded Providers Clinical Support System-Medications for Opioid Use Disorders (PCSS-MOUD). PCSS-MOUD is led by AAAP with a coalition of over 20 national professional healthcare organizations. The three-year grant begins Sept. 30, 2023.
Michelle Lofwall, MD
July 13, 2023
Increased overdoses, many attributed to an influx of synthetic fentanyl, has put a spotlight on those who care for patients with opioid use disorders. Hundreds of prescribers are being targeted in an elaborate scam by imposters posing as DEA agents in an attempt to extort money. Over a series of phone calls, the imposters put their marks at ease, seeming to be on their side. By the time the imposters ask for money, many are willing to pay—just to make the issue go away. Scammers use the names of real DEA agents and alter their voices with artificial intelligence to make them sound as if they have regional accents that are convincing. The scammers are set up overseas.
Drug Enforcement Administration, Department of Justice
July 11, 2023
As Congressionally-mandated, medical practitioners have a new role to help patients fighting to sustain recovery and prevent opioid overdoses. All medical registrants submitting a new or renewing a current registration must attest to completing an eight-hour training to treat patients overcoming opioid and other substance use disorders.
SAMHSA
May 2, 2023
We wanted to share this message from SAMHSA about its Behavioral Health Equity Challenge.
2018 Steering Committee Meeting

Stay in the loop!

Sign up to stay up to date with current content, news and events.